Federico Mingozzi
Directeur Technique/Scientifique/R&D chez SPARK THERAPEUTICS, INC.
Profil
Federico Mingozzi is a professional with a doctorate degree from the University of Ferrara and an MBA from Drexel University.
He has held several positions in the past, including Research Director at Institut National de la Santé & de la Recherche Médicale and Head-Immunology & Liver Gene Transfer at Genethon.
Currently, he holds two positions, one as a Non-Executive Director at Sensorion SA since 2024 and the other as Chief Science & Technology Officer at Spark Therapeutics, Inc. since 2017.
Postes actifs de Federico Mingozzi
| Sociétés | Poste | Début |
|---|---|---|
| SPARK THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 25/09/2017 |
| SENSORION | Directeur/Membre du Conseil | 24/01/2024 |
Anciens postes connus de Federico Mingozzi
| Sociétés | Poste | Fin |
|---|---|---|
Institut National de la Santé & de la Recherche Médicale
 Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Directeur Technique/Scientifique/R&D | 01/09/2017 |
Genethon
 Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Corporate Officer/Principal | 01/09/2017 |
Formation de Federico Mingozzi
| University of Ferrara | Doctorate Degree |
| Drexel University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SENSORION | Health Technology |
| Entreprise privées | 3 |
|---|---|
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Commercial Services |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Health Technology |
